Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02702791
Other study ID # s57963
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 2015
Est. completion date October 2019

Study information

Verified date October 2019
Source KU Leuven
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This randomized control trial will investigate whether the implementation of a telecoaching program, initiated during pulmonary rehabilitation, is able to increase and maintain physical activity and general benefits until six months after rehabilitation discharge.

After three months of pulmonary rehabilitation (3 times a week), patients with COPD will be randomized to either an intervention group which receives an additional telecoaching program on top of the pulmonary rehabilitation, or to the usual care group, which only receives rehabilitation program. Apart from the added telecoaching program to the intervention group, the rehabilitation program will be identical and last for another three months (2 times a week). After discharge, both groups will be followed up for six months.


Recruitment information / eligibility

Status Completed
Enrollment 73
Est. completion date October 2019
Est. primary completion date September 2019
Accepts healthy volunteers No
Gender All
Age group 40 Years to 80 Years
Eligibility Inclusion Criteria:

- Patients with a primary diagnosis of COPD according to internationally accepted guidelines

- Patients that completed three months of the outpatient pulmonary rehabilitation program of Gasthuisberg University Hospital (Leuven, Belgium)

- Current or previous smoking exposure of at least 10 pack years

- Ability to manage electronic devices (smartphone, step counter)

Exclusion Criteria:

- Other predominant respiratory diseases than COPD (asthma, pulmonary hypertension)

- Orthopedic, neurological and muscular co morbidities that could interfere with normal biomechanical movement patterns and the ability to increase physical activity levels

- Patients on the waiting list for lung transplantation

Study Design


Related Conditions & MeSH terms

  • Pulmonary Disease, Chronic Obstructive

Intervention

Behavioral:
Telecoaching
Pedeometer based goals and telecoaching support
Other:
pulmonary rehabilitation
Conventional pulmonary rehabilitation along the ATS-ERS guidelines, total duration 6 months.

Locations

Country Name City State
Belgium University Hospitals Leuven Leuven Vlaams Brabant

Sponsors (2)

Lead Sponsor Collaborator
KU Leuven Conselho Nacional de Desenvolvimento Científico e Tecnológico

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in physical activity (number of steps) At three and six months of pulmonary rehabilitation and three and six months of follow up
Secondary Changes in physical activity (time spent in moderate activity) At three and six months of pulmonary rehabilitation and three and six months of follow up
Secondary Changes in pulmonary rehabilitation outcomes (Quadriceps force) At three and six months of pulmonary rehabilitation and three and six months of follow up
Secondary Changes in pulmonary rehabilitation outcomes (Functional exercise capacity) At three and six months of pulmonary rehabilitation and three and six months of follow up
Secondary Changes in pulmonary rehabilitation outcomes (Maximal exercise capacity) At three and six months of pulmonary rehabilitation and six months of follow up
Secondary Changes in pulmonary rehabilitation outcomes (Endurance exercise capactity) At three and six months of pulmonary rehabilitation and six months of follow up
Secondary Changes in pulmonary rehabilitation outcomes (Quality of life) At three and six months of pulmonary rehabilitation and six months of follow up
See also
  Status Clinical Trial Phase
Completed NCT05043428 - The Roles of Peers and Functional Tasks in Enhancing Exercise Training for Adults With COPD N/A
Completed NCT00528996 - An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler. Phase 2
Completed NCT03740373 - A Study to Assess the Pulmonary Distribution of Budesonide, Glycopyrronium and Formoterol Fumarate Phase 1
Completed NCT05393245 - Safety of Tiotropium + Olodaterol in Chronic Obstructive Pulmonary Disease (COPD) Patients in Taiwan: a Non-interventional Study Based on the Taiwan National Health Insurance (NHI) Data
Completed NCT05402020 - Effectiveness of Tiotropium + Olodaterol Versus Inhaled Corticosteroids (ICS) + Long-acting β2-agonists (LABA) Among COPD Patients in Taiwan
Completed NCT04011735 - Re-usable Respimat® Soft MistTM Inhaler Study
Enrolling by invitation NCT03075709 - The Development, Implementation and Evaluation of Clinical Pathways for Chronic Obstructive Pulmonary Disease (COPD) in Saskatchewan
Completed NCT03764163 - Image and Model Based Analysis of Lung Disease Early Phase 1
Completed NCT00515268 - Endotoxin Challenge Study For Healthy Men and Women Phase 1
Completed NCT04085302 - TARA Working Prototype Engagement Evaluation: Feasibility Study N/A
Completed NCT03691324 - Training of Inhalation Technique in Hospitalized Chronic Obstructive Pulmonary Disease (COPD) Patients - a Pilot Study N/A
Completed NCT02236611 - A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium 62.5 Microgram (mcg) Compared With Glycopyrronium 44 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Phase 4
Completed NCT00153075 - Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD) Phase 4
Completed NCT01009463 - A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Phase 3
Completed NCT01017952 - A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Phase 3
Completed NCT04882124 - Study of Effect of CSJ117 on Symptoms, Pharmacodynamics and Safety in Patients With COPD Phase 2
Completed NCT02853123 - Effect of Tiotropium + Olodaterol on Breathlessness in COPD Patients Phase 4
Completed NCT02619357 - Method Validation Study to Explore the Sensitivity of SenseWear Armband Gecko for Measuring Physical Activity in Subjects With Chronic Obstructive Pulmonary Disease (COPD) & Asthma Phase 1
Recruiting NCT05858463 - High Intensity Interval Training and Muscle Adaptations During PR N/A
Not yet recruiting NCT05032898 - Acute Exacerbation of Chronic Obstructive Pulmonary Disease Inpatient Registry Study Stage II